The rapid infuser market is expected to record a 4.5% CAGR from 2023 to 2033, from USD 1,056.3 million in 2023 to USD 1,639.8 million in 2033. Rapid Infuser devices play a crucial role in critical and emergency operations such as trauma and emergency surgery, labor and delivery, intensive care, and anesthesia.
Such operations require fluid infusion devices, which are a crucial component of critical patient care. As a result, one of the key factors propelling the infuser market's quick growth is likely to be the rising expense of such urgent and necessary surgical treatments.
The rapid infuser device can deliver fluid in a continuous flow that ranges from slow to fast (human bodily fluid). Rapid infusion systems are frequently utilized in emergencies to administer efficient and secure medication to patients experiencing hypovolemic shock or substantial blood loss.
| Report Attribute | Details |
|---|---|
| Rapid Infuser Market Value (2023) | USD 1,056.3 million |
| Rapid Infuser Market Anticipated Value (2033) | USD 1,639.8 million |
| Rapid Infuser Market Growth Rate (2023 to 2033) | 4.5% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rapid infuser market was USD 1,008.2 million by 2022, recording a CAGR of 4.1% from 2018 to 2022. The global market’s absolute dollar growth is USD 51.9 million.
Following Surgical Procedures Typically Include the use of a Rapid Infuser Device:
| Historical CAGR (2018 to 2022) | 4.1% |
|---|---|
| Forecast CAGR (2023 to 2033) | 4.5% |
Short Term (2023 to 2026): A key component of market expansion is likely to be the need to supply the fluid as promptly, practically, and efficiently as possible.
Medium Term (2026 to 2029): An important element in the market's expansion over this timeframe is expected to be the rise in asthma cases brought on by air pollution, respiratory illnesses, and COPD caused owing to smoking and exposure to dust.
Long Term (2029 to 2033): According to FMI's assessment, manufacturers and suppliers of rapid Infuser devices are expected to be rigorously assessing the effects of different strategies, goods, and activities to be competitive over the medium to long-term period.
As per the FMI analysts, the market is projected to reach a valuation of USD 1,639.8 million by 2033.
| Year | Valuation |
|---|---|
| 2016 | USD 1,065.15 million |
| 2021 | USD 1,283.50 million |
| 2022 | USD 1,008.2 million |
| 2023 | USD 1,056.3 million |
| 2033 | USD 1,639.8 million |
One of the key factors propelling the infuser market is the most practical and effective way to provide fluids in a short amount of time. Also, the use of this system in anesthesia centers has increased over time as a result of product developments and the application of information and sensing technologies.
The need for rapid infusers is rising as a result of the increased usage of hypothermia in cases of blood loss or injury following surgery. The extensive transfusion required to meet the increased demand for blood, plasma, and crystalloid fluids creates new opportunities for industrial development.
Principal Consultant
Rapid infusion techniques reduce the incidence of coagulopathy and hypothermia in trauma patients. However, employing rapid infusers necessitates technical knowledge and experience. A lack of technical knowledge about how to operate this equipment can lead to death. Some research also suggests that employing a rapid infuser increases the risk of death, especially in large-size transfusions conducted on trauma patients.
The impact of a fatal accident can be accurately predicted by medical services. According to the World Health Organization, more than 5 million people die from injuries each year. As a result, accidental or traumatic death continues to be a serious public health issue. The patient care system is jeopardized due to a lack of quality standards in trauma and emergency medical services. The high cost of conventional rapid infusion devices acts as a significant deterrent to adoption. Slow implementation of rapid infusion devices in hospitals due to a lack of understanding has a detrimental impact on market prospects, particularly in emerging countries and rural areas.
Infections at surgical sites are a significant concern for hospitals and healthcare practitioners. Infections obtained in the hospital as a result of contaminated operating room settings or surgical tools are referred to as surgical site infections. SSIs are dangerous to patients and are linked to longer hospital stays and increased healthcare costs. When a patient loses a lot of blood during surgery, blood transfusions must be done correctly and in a clean environment.
Rapid infusion devices aid in the most effective fluid infusion, lowering the risk of SSI. Advanced equipment in the emergency department and operating rooms helps healthcare workers to focus on patients without distractions. Rapid infusers are essential medical equipment that needs to be handled carefully. Modern rapid infusers have just entered the market, offering quick delivery of blood or fluid with basic equipment procedures, including starting the unit with a button press. Ultrasonic air detectors and safety valves ensure that there is no air or bubbles in the lines. Rapid infusers are a device that every hospital should have, and their demand is expected to increase as technology progresses.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | United States |
|---|---|
| CAGR (2018 to 2022) | 4.3% |
| Valuation (2023 to 2033) | USD 598.5 million |
| Country | China |
|---|---|
| CAGR (2018 to 2022) | 4.9% |
| Valuation (2023 to 2033) | USD 186.2 million |
| Country | Canada |
|---|---|
| CAGR (2018 to 2022) | 2.0% |
| Valuation (2023 to 2033) | USD 12.3 million |
| Country | Germany |
|---|---|
| CAGR (2018 to 2022) | 4.4% |
| Valuation (2023 to 2033) | USD 74.9 million |
| Country | United Kingdom |
|---|---|
| CAGR (2018 to 2022) | 4.0% |
| Valuation (2023 to 2033) | USD 52.8 million |
With a total market share of about 97.4% in 2021, the United States dominates the North American region and is anticipated to continue expanding at the same rate for the duration of the forecast period. Since these devices are crucial for emergency and essential operative procedures like trauma and emergency operations, the United States is likely to be the significant market for rapid infusers. The country's growing procedures have created a significant demand for efficient fluid infusion devices, which are an essential component of life-saving medical care.
In 2020, North America was expected to have significant growth in the rapid infuser market. Access to cutting-edge healthcare technologies, severe healthcare regulations, and innovations in patient care are all driving the industry forward. Lifestyle-related disorders, as well as trauma and injury scenarios, are driving the need for rapid infusers in North American healthcare facilities, with the United States likely to account for a sizable market share. Also, as technology advances, the market for rapid infusers in North America is projected to benefit from products that can address an array of patient healthcare needs. Besides, a variety of market participants are present in North America, which helps to consolidate market positioning.
Good healthcare infrastructure is a significant driver driving rapid infusion growth in European Union (EU) countries. Long-term growth in the rapid infusers market in Europe is expected to be driven by the need for cost-cutting in healthcare institutions, as well as the increasing surgical procedures conducted in the region. Besides, the rising demand for home healthcare, not just in the EU but also in developing Central and Eastern European markets, is likely to open up new potential for companies in the future.
Russia is expected to record a CAGR of 3.2% in the rapid infuser market during the forecast period. According to the Russian Federation, the SSI rates are significantly higher in Russia. There is a lesser risk of contracting SSI or hospital-acquired infections when using a rapid infusion approach than when using the more conventional pull-push infusion technique. Hence, it is expected to fuel the market in the region to advance during the forecast period from 2023 to 2033.
China holds an 86.5% share in the rapid infuser market in East Asia in 2021 and is projected to record a CAGR of 6.0% during the forecast period. The growth of the market is associated with an increased incidence of intraoperative hypothermia, which raises the demand for rapid infusers. According to a national study in China, the overall incidence of intraoperative hypothermia is as high as 44.3%.
Besides, rising healthcare costs and rapidly improving medical infrastructure are expected to drive market growth during the forecast period in China.
India holds a 66.0% share in the rapid infuser market in 2021 and is projected to record a significant CAGR of 5.8% during the forecast period. This growth is primarily due to advancements in the rapid infuser system in the region. A significant scientific discovery led to the devices' continued advancement as a result of the rising incidence of diseases and the growing incidence of urgent and crucial surgical procedures. Thus, the market in India is considered an emerging market for rapid infusers during the forecast period.
In Asia Pacific, which is expected to expand more quickly than the rest of the world, rapid infusers are well-represented. Rapid infusers are likely to gain popularity as more individuals and healthcare professionals are aware of quality and safety norms. Substantial development is anticipated as a result of the region's significant population base, the emergence of middle-class families, and the expansion of healthcare access.
Due to its access to cheap labor, improved intellectual property protections, and significant investments in Research and Development activities, Asia Pacific has developed into an important MedTech hub. Rapid infuser penetration is still low in the area, creating enormous market opportunities. Local competitors are projected to face reduced competition, favoring the market's leaders.
Trolley mounted rapid infuser is projected to record a significant CAGR of 5.3% over the forecast period, with a market share of around 65.4% in 2023, because it allows ease in operation due to movability and can be shifted anywhere within the facility. In terms of product, the trolley-mounted devices segment holds a significant share in the rapid infuser market. The growth of this segment is primarily attributed to its benefits over handheld devices.
The hospital segment is likely to lead the rapid infuser market with more than 59.8% market share in 2023. The hospital segment is expected to dominate the end-user category of the rapid infuser market due to the increase in hospitals and the surge in emergency patients.
Besides, the availability of highly skilled medical professionals that provide better treatment experience is also likely to contribute to the significant market share during the forecast period.
The key competitors in the market for rapid infusers are concentrating their efforts on growing both their geographic reach and their product offerings.
This is expected to aid market participants in expanding both their product offerings and market presence. Hence, their entire revenue share in the global market for rapid infusion increased.
Given Below are a Few Examples of the Key Strategies Followed by the Manufacturers:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | USD 1,056.3 million |
| Market Size Value in 2033 | USD 1,639.8 million |
| Market Analysis | USD million for Value |
| Key Region Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; The Middle East and Africa |
| Key Segments | By Product, By Usability, By End User, By Regional |
| Key Companies Profiled | Smith’s Medical; GE Healthcare; 3M Company; BD; Stryker Corporation; ZOLL Medical Corporation; Belmont Instrument; Smisson-Cartledge Biomedical; Keewell Medical Technology Co. Ltd; Teleflex Incorporated; Biegler GmbH; ALC "TahatAksi" |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to surpass USD 1,639.8 million by 2033.
As the demand for efficient treatment options for hypothermia and excessive blood loss in operational settings and trauma develops, the usage of rapid infusers is likely to increase.
The market size is anticipated to be USD 1,056.3 million in 2023.
The rapid infuser market is expected to record a CAGR of 4.5% during the forecast period.
North America is expected to dominate the rapid infuser market.
1. Executive Summary | Rapid Infuser Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Trolley Mounted Devices 5.2. Hand-Held Devices 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Usability 6.1. Single-Use Devices 6.2. Reusable Devices 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Hospitals 7.2. Ambulatory Surgical Centres 7.3. Speciality Clinics 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. South Asia 8.5. East Asia 8.6. Oceania 8.7. MEA 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Smith’s Medical 18.2. GE Healthcare 18.3. 3M Company 18.4. BD 18.5. Stryker Corporation 18.6. ZOLL Medical Corporation 18.7. Belmont Instrument 18.8. Smisson-Cartledge Biomedical 18.9. Keewell Medical Technology Co. Ltd 18.10. Teleflex Incorporated 18.11. Biegler GmbH 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Rapid Infuser Market
